There is a lack of studies that evaluate the association between normal weight central obesity and subsequent outcomes in patients with premature acute coronary syndrome (ACS). We evaluated 338 consecutive male patients (aged ≤ 55 years) with premature ACS. The primary outcomes were all-cause mortality and major adverse cardiac and cerebrovascular events (MACCE). We compared the hazard ratios (HRs) in patients with and without normal weight central obesity using multivariable Cox proportional hazard models. All-cause mortality (16.8%) of patients with normal weight central obesity was much higher than those (7.1%) without normal weight central obesity (P = .008). The incidence of MACCE in patients with and without normal weight central obesity were 40.7 and 23.6% (P = .001), respectively. After multivariable adjustment, the risks of all-cause mortality and MACCE were significantly higher in patients with normal weight central obesity than those without normal weight central obesity (adjusted HR: 1.83; 95% confidence interval [CI]: 1.04-3.31; P = .004 and adjusted HR: 1.62; 95% CI: 1.18-2.27; P = .017, respectively). In conclusion, the risks of all-cause mortality and MACCE were significantly higher in male patients with premature ACS with normal weight central obesity than in those without normal weight central obesity.
NiedzielaJHudzikBNiedzielaN, et al.The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014;29(11):801–12.
2.
NCD Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387(10026):1377–96.
3.
HuLHuangXYouC, et al.Prevalence of overweight, obesity, abdominal obesity and obesity-related risk factors in southern China. PLoS One. 2017;12(9):e0183934.
4.
PelletierRChoiJWintersN, et al.Sex differences in clinical outcomes after premature acute coronary syndrome. Can J Cardiol. 2016;32(12):1447–53.
5.
LamelasPSchwalmJQuaziI, et al.Effect of body mass index on clinical events after acute coronary syndromes. Am J Cardiol. 2017;120(9):1453–59.
6.
KadakiaMBFoxCSSciricaBM, et al.Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial. Heart. 2011;97(21):1782–87.
7.
De SchutterALavieCJMilaniRV. The impact of obesity on risk factors and prevalence and prognosis of coronary heart disease-the obesity paradox. Prog Cardiovasc Dis. 2014;56(4):401–08.
8.
SharmaAVallakatiAEinsteinAJ, et al.Relationship of body mass index with total mortality, cardiovascular mortality, and myocardial infarction after coronary revascularization: evidence from a meta-analysis. Mayo Clin Proc. 2014;89(8):1080–100.
9.
SharmaSBatsisJACoutinhoT, et al.Normal-weight central obesity and mortality risk in older adults with coronary artery disease. Mayo Clin Proc. 2016;91(3):343–51.
10.
CoutinhoTGoelKCorrêa De SáD, et al.Central obesity and survival in subjects with coronary artery disease. J Am Coll Cardiol. 2011;57(19):1877–86.
11.
BowmanKAtkinsJLDelgadoJ, et al.Central adiposity and the overweight risk paradox in aging: follow-up of 130,473 UK Biobank participants. Am J Clin Nutr. 2017;106(1):130–5.
12.
EmdinCAKheraAVNatarajanP, et al.Genetic association of waist-to-hip ratio with cardiometabolic traits, type 2 diabetes, and coronary heart disease. JAMA. 2017;317(6):626–34.
13.
MyintPKKwokCSLubenRNWarehamNJKhawKT. Body fat percentage, body mass index and waist-to-hip ratio as predictors of mortality and cardiovascular disease. Heart. 2014;100(20):1613–9.
14.
CoutinhoTGoelKCorrêa De SáD, et al.Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease. J Am Coll Cardiol. 2013;61(5):553–60.
15.
DimitriadisKTsioufisCMazarakiA, et al.Waist circumference compared with other obesity parameters as determinants of coronary artery disease in essential hypertension: a 6-year follow-up study. Hypertens Res. 2016;39(6):475–9.
16.
KocovskiLLeeJDParpiaSFernandesJNairV. Association of waist-hip ratio to sudden cardiac death and severe coronary atherosclerosis in medicolegal autopsies. Am J Forensic Med Pathol. 2017;38(3):226–8.
17.
SahakyanKRSomersVKRodriguez-EscuderoJP, et al.Normal-weight central obesity: implications for total and cardiovascular mortality. Ann Intern Med. 2015;163(11):827–35.
18.
HammCWBassandJPAgewallS, et al.ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(23):2999–3054.
19.
AfsharMPiloteLDufresneL, et al.Lipoprotein(a) interactions with low-density lipoprotein cholesterol and other cardiovascular risk factors in premature acute coronary syndrome (ACS). J Am Heart Assoc. 2016;5(4):e3012.
20.
NishidaCKoGTKumanyikaS. Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO expert consultation on waist circumference and waist-hip ratio. Eur J Clin Nutr. 2010;64(1):2–5.
21.
DobiásováMFrohlichJSedováMCheungMCBrownBG. Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. J Lipid Res. 2011;52(3):566–71.
22.
OnatACanGKayaHHergençG. “Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol. 2010;4(2):89–98.
23.
AchillesAMohringADannenbergL, et al.Analgesic medication with dipyrone in patients with coronary artery disease: relation to MACCE. Int J Cardiol. 2017;236:76–81.
24.
KooCYDragerLFSethiR, et al.Obstructive sleep apnea and diabetes independently add to cardiovascular risk after coronary revascularization. Diabetes Care. 2018;41(2):e12–4.
25.
YusufSHawkenSOunpuuS, et al.Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497):1640–9.
26.
VazquezGDuvalSJacobsDR, et al.Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev. 2007;29:115–28.
27.
BatsisJASinghSLopez-JimenezF. Anthropometric measurements and survival in older Americans: results from the third national health and nutrition examination survey. J Nutr Health Aging. 2014;18(2):123–130.
28.
RodgersRJTschopMHWildingJP. Anti-obesity drugs: past, present and future. Dis Model Mech. 2012;5(5):621–6.
29.
BendzalaMSabakaPCaprndaM, et al.Atherogenic index of plasma is positively associated with the risk of all-cause death in elderly women. Wien Klin Wochenschr. 2017;129(21-22):793–8.
30.
KimSHDesprésJ-PKohKK. Obesity and cardiovascular disease: friend or foe?Eur Heart J. 2015;37(48):3560–8.
31.
AlbrechtS SGordon-LarsenPSternDPopkinBM. Is waist circumference per body mass index rising differentially across the United States, England, China and Mexico?Eur J Clin Nutr. 2015;69(12):1306–12.
32.
FanHLiXZhengL, et al.Abdominal obesity is strongly associated with cardiovascular disease and its risk factors in elderly and very elderly community-dwelling Chinese. Sci Rep. 2016;6:21521.
33.
ZhaoHMaJZhouQ, et al.Investigating the differences of body mass index and waist circumference in the follow-up assessment of patients to cardiac rehabilitation with acute coronary syndrome. Australas Phys Eng Sci Med. 2016;39(4):1007–27.
34.
XuLZhaoHQiuJ, et al.The different effects of BMI and WC on organ damage in patients from a cardiac rehabilitation program after acute coronary syndrome. Biomed Res Int. 2015;2015:942695.
35.
MiyazakiSHiasaYTakahashiT, et al.Waist circumference reduction is more strongly correlated with the improvement in endothelial function after acute coronary syndrome than body mass index reduction. J Cardiol. 2010;55(2):266–73.
36.
LavieCJAlpertMAArenaRMehraMRMilaniRVVenturaHO. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail. 2013;1(2):93–102.
37.
TsujimotoTKajioH. Abdominal obesity is associated with an increased risk of all-cause mortality in patients with HFpEF. J Am Coll Cardiol. 2017;70(22):2739–49.
38.
AndersenKKOlsenTS. The obesity paradox in stroke: lower mortality and lower risk of readmission for recurrent stroke in obese stroke patients. Int J Stroke. 2014;10(1):99–104.
39.
UretskySMesserliFHBangaloreS, et al.Obesity paradox in patients with hypertension and coronary artery disease. Am J Med. 2007;120(10):863–70.
40.
GalalWvan GestelYRBMHoeksSE, et al.The obesity paradox in patients with peripheral arterial disease. Chest. 2008;134(5):925–30.
41.
ParkJAhmadiSStrejaE, et al.Obesity paradox in end-stage kidney disease patients. Prog Cardiovasc Dis. 2014;56(4):415–25.
42.
DoehnerWErdmannECairnsR, et al.Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol. 2012;162(1):20–6.
43.
FerreiraIStehouwerCD. Obesity paradox or inappropriate study designs? Time for life-course epidemiology. J Hypertens. 2012;30(12):2271–5.
44.
TsujimotoTKajioHSugiyamaT. Risks for cardiovascular and cardiac deaths in nonobese patients with diabetes and coronary heart disease. Mayo Clin Proc. 2016;91(11):1545–54.
45.
CarboneSLavieCJArenaR. Obesity and heart failure: focus on the obesity paradox. Mayo Clin Proc. 2017;92(2):266–79.
46.
Van GaalLFMertensILDe BlockCE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875–80.
47.
FerreiraISnijderMBTwiskJW, et al.Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam growth and health longitudinal study. J Clin Endocrinol Metab. 2004;89(6):2632–9.
48.
EbtehajSGruppenEGParviziMTietgeUJFDullaartRPF. The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation. Cardiovasc Diabetol. 2017;16(1):132–41.
49.
CantoJGKiefeCIRogersWJ, et al.Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA. 2011;306(19):2120–7.
50.
DuongMRangarajanSZhangX, et al.Effects of bidi smoking on all-cause mortality and cardiorespiratory outcomes in men from south Asia: an observational community-based substudy of the Prospective Urban Rural Epidemiology Study (PURE). Lancet Glob Health. 2017;5(2):e168–76.
51.
JensenMDRyanDHApovianCM, et al.2013 AHA/ACC/TOS Guideline for the management of overweight and obesity in adults. J Am Coll Cardiol. 2014;63(25 suppl 2):2985–3023.
52.
ChakrabartiSMortonJSDavidgeST. Mechanisms of estrogen effects on the endothelium: an overview. Can J Cardiol. 2014;30(7):705–12.
53.
RicciBCenkoEVasiljevicZ, et al.Acute coronary syndrome: the risk to young women. J Am Heart Assoc. 2017;6(12):e007519.
54.
DeVonHAGrinesCLKrumholzHM, et al.Acute myocardial infarction in women. Circulation. 2016;133:916–47.
55.
GuanXSunGZhengLHuWLiWSunY. Associations between metabolic risk factors and body mass index, waist circumference, waist-to-height ratio and waist-to-hip ratio in a Chinese rural population. J Diabetes Investig. 2016;7(4):601–6.
